World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
87
Citations
28151
World Ranking
793
National Ranking
48

Medicine

D-Index
87
Citations
28408
World Ranking
13627
National Ranking
521

Overview

Joep M. A. Lange was affiliated with the University of Amsterdam in the Netherlands. Their research primarily focused on medicine, with particular contributions in pediatrics, perinatology and child health, applied microbiology and biotechnology, and pharmacology.

The scientist's work covered several main topics, including pharmaceutical studies and practices, antibiotic use and resistance, as well as antibiotics pharmacokinetics and efficacy.

Among their recent papers were:

  • Development and maintenance of consensus recommendations on pediatric outpatient antibiotic therapy in Germany: a framework for rational use, 2025, European Journal of Pediatrics
  • The spread, treatment, and prevention of HIV-1: evolution of a global pandemic, 2020, UNC Libraries

These publications appeared in venues such as the European Journal of Pediatrics and UNC Libraries, each reflecting an aspect of their research interests.

Joep M. A. Lange frequently collaborated with several co-authors, including:

  • Janina Soler Wenglein
  • Arne Simon
  • Reinhard Berner
  • Holger Brockmeyer
  • Johannes Förster

Best Publications

  • Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

    H Schuitemaker;M Koot;N A Kootstra;M W Dercksen

  • Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

    Mette D. Hazenberg;Sigrid A. Otto;Birgit H. B. Van Benthem;Marijke Th. L. Roos

  • A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

    Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella

  • Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.

    Adriano Lazzarin;Bonaventura Clotet;David Cooper;Jacques Reynes

  • Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.

    Marieke Den Brinker;Ferdinand W.N.M. Wit;Pauline M.E. Wertheim-van Dillen;Suzanne Jurriaans

  • Hypertension in sub-saharan Africa: cross-sectional surveys in four rural and urban communities

    Marleen E. Hendriks;Ferdinand W. N. M. Wit;Marijke T. L. Roos;Lizzy M. Brewster

  • Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

    J. M. A. Lange;D. A. Paul;H. G. Huisman;F. De Wolf

  • Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

    Charles A. B. Boucher;Eithne O'Sullivan;Jan W. Mulder;Chitra Ramautarsing

  • Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection.

    M. D. Hazenberg;S. A. Otto;J. W. Cohen Stuart;M. C. Verschuren

  • The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

    Myron S. Cohen;Nick Hellmann;Jay A. Levy;Kevin DeCock

  • The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

    Mark R. Nelson;Christine Katlama;Julio S. Montaner;David A. Cooper

  • Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy

    Ferdinand W. N. M. Wit;Gerrit Jan Weverling;Jan Weel;Suzanne Jurriaans

  • Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

    Pythia T. Nieuwkerk;Mirjam A. G. Sprangers;David M. Burger;Richard M. W. Hoetelmans

  • Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

    Frank van Leth;Prahpan Phanuphak;Erik Stroes;Brian Gazzard

  • Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.

    Janet M. Raboud;Julio S.G. Montaner;Brian Conway;Sandra Rae

  • High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.

    Agnes I. Veldkamp;Gerrit J. Weverling;Joep M. A. Lange;Julio S. G. Montaner

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Antiretroviral drugs and the central nervous system

    Roelien H. Enting;Richard M.w. Hoetelmans;Joep M.a. Lange;David M. Burger

  • Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men

    Frank de Wolf;Joep M. A. Lange;Jose T. M. Houweling;Roel A. Coutinbo

  • Mortality and progression to AIDS after starting highly active antiretroviral therapy.

    van Ai Sighem;van de Ma Mark Wiel;AC Ghani;M Jambroes

Frequent Co-Authors

David A. Cooper
David A. Cooper University of New South Wales
Peter Reiss
Peter Reiss University of Amsterdam
Jan M. Prins
Jan M. Prins University of Amsterdam
Kiat Ruxrungtham
Kiat Ruxrungtham Chulalongkorn University
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Jaap Goudsmit
Jaap Goudsmit Harvard University
Frank Miedema
Frank Miedema Utrecht University
Sven A. Danner
Sven A. Danner University of Amsterdam
David M. Burger
David M. Burger Radboud University
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in microbiology can open doors to various healthcare and research careers. For individuals with unique backgrounds, exploring options like what can a felon go to college for may provide guidance on accessible online degrees that align with science and healthcare fields.

Additionally, careers in healthcare extend beyond traditional lab roles. For example, becoming a functional medicine np salary shows promising earning potential for nurse practitioners focusing on integrative approaches, highlighting the diversity within related medical professions.

Administrative roles also play a crucial part in the microbiology and health sectors. Certifications like certified professional coder (cpc) offer structured career paths in medical coding, essential for healthcare documentation and reimbursement processes.

For those interested in data management and leadership, a master in health information management salary reflects the value of advanced degrees in managing complex health information systems critical to research and patient care. Together, these pathways illustrate the broad opportunities available alongside microbiology studies.

Best Scientists Citing Joep M. A. Lange

Recently Published Articles